readthroughSign in
CompanyCALCNasdaqLa Jolla, CA

CalciMedica, Inc.

Clinical-stage biopharmaceutical company developing small-molecule CRAC channel inhibitors for inflammatory and immunologic diseases.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 10Latest story